Skip to main content
NTHI
NASDAQ Life Sciences

NeOnc Technologies Finalizes $1.45M Private Placement at Significant Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$9.18
Mkt Cap
$208.314M
52W Low
$3.2
52W High
$25
52W Position info
187% above low
Off High info
63% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

NTHI has more than doubled off its 52-week low of $3.2.

Summary

NeOnc Technologies Holdings, Inc. completed a $1.45 million private placement of common stock and warrants at a substantial discount to the current market price, with proceeds for working capital.


Key Events · Financing and Capital Events · NTHI

  • Private Placement Closing

    The company completed a closing of a Securities Purchase Agreement, issuing 201,390 shares of common stock and warrants to purchase an equal number of shares for an aggregate purchase price of $1,450,004.

  • Discounted Pricing

    The shares were sold at $7.20 per share, representing a significant discount of approximately 21.5% compared to the current stock price of $9.18. Warrants are exercisable at $9.00 per share.

  • Use of Proceeds

    The net proceeds from this offering are intended for general working capital purposes.

  • Resale Registration Commitment

    The company will file a resale registration statement for the issued shares and warrant shares no later than ten days after filing its Annual Report on Form 10-K for the year ended December 31, 2025.


Analysis · NTHI · Life Sciences

This 8-K details the final closing of a private placement, where NeOnc Technologies Holdings, Inc. issued 201,390 shares and warrants for an aggregate of $1.45 million. The shares were sold at $7.20, representing a significant discount of approximately 21.5% compared to the current stock price of $9.18. While the capital raise provides funds for working capital, the deep discount at which the securities were issued indicates a potentially challenging financing environment or urgency for capital, leading to substantial dilution for existing shareholders. The company also committed to filing a resale registration statement for these securities. This filing confirms and provides official details for a private placement previously reported in news.

How filings like this one have moved

In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NTHI was trading at $9.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $208.3M. The 52-week trading range was $3.20 to $25.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NTHI - Latest Insights

NTHI
Aug 12, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $4.61 info
Change: -$0.5735 (-11%) info
Market Cap: $119.437M info
NTHI
Aug 12, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.88
Real-time Price: $4.61 info
Change: -$0.2707 (-6%) info
Market Cap: $119.437M info
NTHI
Aug 10, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.57
Real-time Price: $4.61 info
Change: +$1.04 (+29%) info
Market Cap: $119.437M info
NTHI
Aug 10, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.58
Real-time Price: $4.61 info
Change: +$1.03 (+29%) info
Market Cap: $119.437M info
NTHI
Aug 10, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.47
Real-time Price: $4.61 info
Change: +$1.14 (+33%) info
Market Cap: $119.437M info